T Brocker1, A Peter, A Traunecker
1Basel Institute for Immunology, Switzerland.
Researchers created a novel single-chain T cell receptor (TcR) by fusing antibody recognition with T cell signaling. This engineered TcR enables T cells to target specific cells and activate immune responses, offering new possibilities for immunotherapy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: